Navigation Links
KV Pharmaceutical Company Updates Timing of Fiscal 2008 Securities and Exchange Commission Filings
Date:5/30/2008

KV Expects Filings To Be Completed Within Automatic Form 10-K Extension

Period

ST. LOUIS, May 30 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology-differentiated branded products and generic/non-branded prescription pharmaceuticals, announced today that it expects to complete and file its fiscal 2008 Form 10-K with the Securities and Exchange Commission within the automatic extension period ending June 16, 2008 pursuant to a Form 12b-25 filed by the Company today. We also expect the fiscal 2008 Form 10-Q's will be filed by June 16, 2008.

Since the Company filed its fiscal 2007 Form 10-Q's and Form 10-K in March 2008, which incorporated the restatement of 11 years of financial statements and additional interim financial information, the Company has focused on preparing its Form 10-Q's for the first three quarters of fiscal 2008 and Form 10-K for the full fiscal year ended March 31, 2008. Although the Company had sought diligently to file the Form 10-K within 60 days after the end of its fiscal year, the time provided by the automatic extension period to June 16, 2008 is necessary to afford sufficient review by the parties involved.

With the completion of these filings, the Company will be in compliance with all Securities and Exchange Commission periodic filing requirements.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology- distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology-distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its branded prescription pharmaceutical subsidiary. '/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... 01, 2015 , ... Calvary Hospital today announced that it is embarking on ... goal is to bring this Torah – dating from 1880 – back to kosher ... services. , Scroll No. 515, from the town of Taus-Domazlice, is on permanent ...
(Date:8/1/2015)... ... 2015 , ... On Tuesday, July 28th, Symantec released a security industry ... behind the attack on Anthem Inc. which resulted in one of the largest data ... and spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO of ...
(Date:8/1/2015)... (PRWEB) , ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – ... trek of the Appalachian Trail by stepping off Springer Mountain and heading north. ... On July 26th Phil reached Connecticut and was greeted by friends and family. He ...
(Date:7/31/2015)... (PRWEB) , ... August 01, 2015 , ... The Honor ... Global Advisory Panel on the Future of Nursing (GAPFON) 20-21 July 2015 in San ... to participate in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by Becker’s Healthcare ... health analytics , Jvion continues to disrupt the predictive analytic and big data ... patient and population level illness to drive prevention and better health outcomes. Most ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Announces Plans to Restore Historic Torah 2Health News:Calvary Hospital Announces Plans to Restore Historic Torah 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... Oct. 31Like normal tissue, tumors thrive on nutrients carried ... of new blood vessels is a hallmark of cancer, ... can keep tumors from growing, too. To better understand ... would like to make detailed maps of the complete ...
... to popular belief, most college students don,t gain anywhere near ... nationwide study. Rather than adding "the freshman 15," as ... 2.5 and 3.5 pounds during the first year of college. ... gain, the study revealed. The typical freshman only gains about ...
... An international collaboration of scientists, including researchers at ... Skin Diseases (NIAMS), a part of the National ... that causes a rare childhood disease characterized predominantly ... that the disorder, named chronic atypical neutrophilic dermatosis ...
... hypertension (PAH) is a rare form of pulmonary hypertension (PH) that ... people out of one million people worldwide per year - most ... 40. While the numbers may not seem significant, the disease ... the causes of PAH remain unknown. As the ...
... , MONDAY, Oct. 31 (HealthDay News) -- Construction workers ... injuries and an increased risk of work-related illness and death, ... national sources and found that a construction worker has a ... 45-year career, and a 1-in-200 risk of being fatally injured ...
... by the Institute for Health Metrics and Evaluation (IHME) ... improved methods for analyzing verbal autopsies a method ... a complete vital registration system are fast, effective, ... to understand disease trends., While many high-income countries such ...
Cached Medicine News:Health News:The 'freshman 15' is just a myth, nationwide study reveals 2Health News:The 'freshman 15' is just a myth, nationwide study reveals 3Health News:NIH scientists discover link among spectrum of childhood diseases 2Health News:LA BioMed's Dr. Ronald Oudiz impacting lives of those with pulmonary hypertension 2Health News:'Hard Hats' Still Have High Rates of Injury, Illness: Report 2Health News:IHME develops fast, affordable ways for countries to better identify causes of death in populations 2Health News:IHME develops fast, affordable ways for countries to better identify causes of death in populations 3Health News:IHME develops fast, affordable ways for countries to better identify causes of death in populations 4
(Date:7/31/2015)... 2015  In today,s ever-changing marketplace, call centers must ... increasingly connected, and increasingly impatient with slow service. The ... channels and tools is driving call centers to explore ... According to research by benchmarking firm, Best Practices, ... in a call center study realize the impact of ...
(Date:7/31/2015)... , July 31, 2015 The ... press release on July 28, 2015, "Surviving Your ... Launches Fundraising for Patient Safety." A ... sentence should read: "PPAHS is a ... Patients on Opioids. For more information on the National ...
(Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4
... VIENNA, Va., June 20, 2007 /PRNewswire/ ... announced the successful completion of,pharmacokinetic and ... hormone, long-acting interferon beta and,long-acting erythropoietin. ... demonstrated superb durability of the long-acting,proteins, ...
... /PRNewswire-FirstCall/ -- Amylin,Pharmaceuticals, Inc. today announced that ... injection and,SYMLIN(R) (pramlintide acetate) injection, and its ... Diabetes Association's,(ADA) 67th Annual Scientific Sessions being ... 26. The company will also host an ...
Cached Medicine Technology:Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 2Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 3Modigene Announces Successful Completion of Pharmacokinetic &,Pharmacodynamic Pre-Clinical Experiments for Proprietary,Long-Acting Human Growth Hormone, Long-acting Interferon Beta and,Long-acting Erythropoietin 4Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 2Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 3Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 4
... the only four-color, automated benchtop flow cytometry ... cell sorting. Designed specifically to support a ... offers software instrument control, auto-sample loading, and ... productivity. FACSCalibur is fully modular so it ...
... cytometer especially suited for cell analysis ... CyFlow allows to analyze scatter signals ... fluorescence channels. Data acquisition, analysis, and ... built-in PC employing Partec DPAC software, ...
This unique system combines the analytical power of a research cytometer into a compact, truly walk away, clinical analyzer ergonomically designed to expedite sample throughput....
The Cytomics FC 500 Series delivers flexible testing, powerful software and a user-friendly interface features that help researchers optimize their overall workflow efficiency while maintaining true ...
Medicine Products: